Susan Berson and Brent Henry Recognized as Health Care Trailblazers by the National Law Journal
Filter by:
As Congress Preps PAMA Reform Bill, Legislators Ask CMS to Delay Law's Implementation
August 28, 2025
Health Law Practice Chair and Health Care Enforcement Defense Practice Co-chair Karen Lovitch shared insights with 360Dx on recent letters sent by legislators to the Centers for Medicare and Medicaid Services (CMS), which request a delay in upcoming price cuts and reporting requirements related to the Protecting Access to Medicare Act (PAMA). Karen notes that the requests appear to fall within CMS's regulatory authority and align with past congressional actions aimed at maintaining stability in lab reimbursement policy.
Mintz Honored with NLADA Beacon of Justice Award
August 21, 2025
Mintz will receive a 2025 Beacon of Justice Award from the National Legal Aid & Defender Association (NLADA) for efforts to sustain equal justice for families and communities. This is the sixth consecutive year that Mintz has won this award.
Mintz Advises Oppenheimer & Co. and Initial Purchasers in $475M Convertible Senior Notes Offering by WisdomTree
August 19, 2025
Mintz represented Oppenheimer & Co., as sole book-running manager, and Craig-Hallum Capital Group and Northland Securities, as co-managers, in the private placement of $475 million aggregate principal amount of 4.625% Convertible Senior Notes due 2030 issued by WisdomTree, Inc (NYSE: WT) (“WisdomTree”). The notes were sold to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933.
Of Counsel Michelle Capezza recently shared insights with Fiduciary News in light of the recent "Democratizing Access to Alternative Assets for 401(K) Investors" executive order. The article emphasizes that fiduciaries must respond quickly and carefully to new regulations, protecting participants while adapting to a more complex retirement landscape.
SEC’s Pharmaceutical Insider Trading Case Yields Quick Deals
August 19, 2025
Bloomberg Law featured a statement from Member Jason P.W. Halperin in its coverage of a pharmaceutical insider trading case brought by the SEC. Jason and the Mintz team of Sean Prosser and Elizabeth Platonova represented Robert Yedid in reaching a resolution in which the client pled guilty and, along with the other defendants, entered into consent orders with the SEC.